FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

387086006: Levodopa (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461264012 Levodopa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481200014 Levodopa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1491864012 L-3-hydroxytyrosine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3766620018 L-dopa en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3116901000052119 levodopa sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levodopa (substance) Is a Dopamine agent false Inferred relationship Some
Levodopa (substance) Is a Dihydroxyphenylalanine true Inferred relationship Some
Levodopa (substance) Has disposition (attribute) Dopamine receptor agonist (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form) Has active ingredient True Levodopa (substance) Inferred relationship Some 2
Levodopa only product in oral dose form Has active ingredient True Levodopa (substance) Inferred relationship Some 1
Carbidopa and levodopa only product in enteral dose form Has active ingredient True Levodopa (substance) Inferred relationship Some 1
karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 100 milligram, oral tablett Has precise active ingredient False Levodopa (substance) Inferred relationship Some 1
karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 100 milligram, oral tablett Has basis of strength substance (attribute) False Levodopa (substance) Inferred relationship Some 1
karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 250 milligram, oral tablett Has basis of strength substance (attribute) False Levodopa (substance) Inferred relationship Some 1
karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 250 milligram, oral tablett Has precise active ingredient False Levodopa (substance) Inferred relationship Some 1
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Benserazide 12.5 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Benserazide 12.5 mg and levodopa 50 mg oral tablet Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Product containing benserazide and levodopa in oral dose form (medicinal product form) Has active ingredient True Levodopa (substance) Inferred relationship Some 1
Benserazide and levodopa only product in oral dose form Has active ingredient True Levodopa (substance) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet Has precise active ingredient True Levodopa (substance) Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 2
Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) Has active ingredient True Levodopa (substance) Inferred relationship Some 1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet Has precise active ingredient True Levodopa (substance) Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
karbidopa (som karbidopamonohydrat) 10 milligram och levodopa 100 milligram, oral tablett Has basis of strength substance (attribute) False Levodopa (substance) Inferred relationship Some 1
karbidopa (som karbidopamonohydrat) 10 milligram och levodopa 100 milligram, oral tablett Has precise active ingredient False Levodopa (substance) Inferred relationship Some 1
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Benserazide 25 mg and levodopa 100 mg oral capsule Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Benserazide 25 mg and levodopa 100 mg oral capsule Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Carbidopa- and levodopa-containing product in oromucosal dose form Has active ingredient True Levodopa (substance) Inferred relationship Some 1
karbidopa (som karbidopamonohydrat) 12,5 milligram och levodopa 50 milligram, oral tablett Has basis of strength substance (attribute) False Levodopa (substance) Inferred relationship Some 1
karbidopa (som karbidopamonohydrat) 12,5 milligram och levodopa 50 milligram, oral tablett Has precise active ingredient False Levodopa (substance) Inferred relationship Some 1
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet Has precise active ingredient True Levodopa (substance) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Levodopa (substance) Inferred relationship Some 2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Levodopa (substance) Inferred relationship Some 2

Start Page 2 of 2


This concept is not in any reference sets

Back to Start